Celcuity Inc.

9.03-0.1000-1.10%Vol 34.35K1Y Perf -9.51%
Oct 3rd, 2023 16:00 DELAYED
BID8.23 ASK9.88
Open9.14 Previous Close9.13
Pre-Market- After-Market-
 - -  - -%
Target Price
23.50 
Analyst Rating
Strong Buy 1.33
Potential %
160.24 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-20/-33/-50 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-33/-43/-62 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
99/99/98 
Income Ranking
 —    -
Price Range Ratio 52W %
22.17 
Earnings Rating
Strong Buy
Market Cap199.47M 
Earnings Date
9th Nov 2023
Alpha0.00 Standard Deviation0.24
Beta0.60 

Today's Price Range

8.839.32

52W Range

7.5014.40

5 Year PE Ratio Range

-21.30-17.60

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
-5.14%
1 Month
-7.31%
3 Months
-9.87%
6 Months
-9.06%
1 Year
-9.51%
3 Years
61.02%
5 Years
-68.32%
10 Years
-

TickerPriceChg.Chg.%
CELC9.03-0.1000-1.10
AAPL172.40-1.3500-0.78
GOOG133.30-1.8700-1.38
MSFT313.39-8.4100-2.61
XOM115.830.20000.17
WFC38.67-0.9400-2.37
JNJ155.340.19000.12
FB196.640.99000.51
GE107.76-1.0300-0.95
JPM142.71-1.0600-0.74
Financial StrengthValueIndustryS&P 500US Markets
8.70
9.70
0.26
0.35
-18.00
Leverage Ratio 1.40
ProfitabilityValueIndustryS&P 500US Markets
-
-
-
-
-
RevenueValueIndustryS&P 500US Markets
0.00
0.00
-
-
Earnings HistoryEstimateReportedSurprise %
Q02 2023-0.67-0.661.49
Q01 2023-0.65-0.5515.38
Q04 2022-0.54-0.69-27.78
Q03 2022-0.49-0.75-53.06
Q02 2022-0.47-0.67-42.55
Q01 2022-0.51-0.53-3.92
Q04 2021-0.40-0.45-12.50
Q03 2021-0.35-0.41-17.14
Earnings Per EndEstimateRevision %Trend
9/2023 QR-0.742.63Positive
12/2023 QR-0.90-20.00Negative
12/2023 FY-2.77-2.97Negative
12/2024 FY-2.48-3.33Negative
Next Report Date9th Nov 2023
Estimated EPS Next Report-0.74
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume34.35K
Shares Outstanding22.09K
Shares Float9.54M
Trades Count958
Dollar Volume313.00K
Avg. Volume64.43K
Avg. Weekly Volume58.59K
Avg. Monthly Volume77.67K
Avg. Quarterly Volume57.04K

Celcuity Inc. (NASDAQ: CELC) stock closed at 9.13 per share at the end of the most recent trading day (a -0.11% change compared to the prior day closing price) with a volume of 42.79K shares and market capitalization of 199.47M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 30 people. Celcuity Inc. CEO is Brian F. Sullivan.

The one-year performance of Celcuity Inc. stock is -9.51%, while year-to-date (YTD) performance is -34.83%. CELC stock has a five-year performance of -68.32%. Its 52-week range is between 7.5 and 14.402, which gives CELC stock a 52-week price range ratio of 22.17%

Celcuity Inc. currently has a PE ratio of -5.10, a price-to-book (PB) ratio of 4.27, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of -, a ROA of -45.24%, a ROC of -46.03% and a ROE of -60.24%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Celcuity Inc., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.74 for the next earnings report. Celcuity Inc.’s next earnings report date is 09th Nov 2023.

The consensus rating of Wall Street analysts for Celcuity Inc. is Strong Buy (1.33), with a target price of $23.5, which is +160.24% compared to the current price. The earnings rating for Celcuity Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Celcuity Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Celcuity Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 13.92, ATR14 : 0.59, CCI20 : -83.97, Chaikin Money Flow : 0.19, MACD : -0.11, Money Flow Index : 62.94, ROC : -7.50, RSI : 39.69, STOCH (14,3) : 20.68, STOCH RSI : 0.00, UO : 39.55, Williams %R : -79.32), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Celcuity Inc. in the last 12-months were: Brian F. Sullivan (Buy at a value of $1 499 996), Buller Richard (Sold 1 975 shares of value $20 406 ), Buller Richard E (Sold 300 shares of value $3 537 ), Furcht Leo (Buy at a value of $103 200), Leo T. Furcht (Option Excercise at a value of $400), Polly A. Murphy (Buy at a value of $48 383), Richard E. Buller (Sold 1 200 shares of value $12 655 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (66.67 %)
2 (66.67 %)
2 (66.67 %)
Moderate Buy
1 (33.33 %)
1 (33.33 %)
1 (33.33 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.33
Strong Buy
1.33
Strong Buy
1.33

Celcuity Inc.

Celcuity Inc is active in the healthcare domain. It is a cellular analysis company that is discovering new cancer sub-types and commercialising diagnostic tests designed to significantly improve the clinical outcomes of cancer patients treated with targeted therapies. The company's proprietary CELx diagnostic platform uses the patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it.

CEO: Brian F. Sullivan

Telephone: +1 763 392-0767

Address: 16305 36th Avenue North, Minneapolis 55446, MN, US

Number of employees: 30

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

54%46%

Bearish Bullish

58%42%

Bearish Bullish

51%49%

 

News

Stocktwits